Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Neurology

What is the LGIT Diet for Angelman Syndrome Seizures?

At a Glance

The Low Glycemic Index Treatment (LGIT) is an effective dietary therapy for managing Angelman syndrome seizures. It stabilizes blood sugar by limiting carbs to foods with a glycemic index under 50. LGIT offers a more flexible alternative to the classic keto diet but requires dietitian supervision.

The Low Glycemic Index Treatment (LGIT) is a specialized dietary therapy used to help manage seizures in people with Angelman syndrome [1]. It serves as a more flexible, less restrictive alternative to the classic ketogenic diet [2]. The LGIT focuses on consuming carbohydrates that are digested slowly, which prevents rapid spikes in blood sugar. Clinical evidence shows it is an effective, non-pharmacologic option that can reduce seizure frequency and is generally easier for families to maintain [1][3][4].

What is the LGIT Diet?

The LGIT diet focuses on the glycemic index (GI) of foods—a measure of how quickly a food raises blood sugar levels. Instead of strictly limiting total calories or focusing solely on total carbohydrates like the classic ketogenic diet, the LGIT restricts carbohydrate sources to those with a glycemic index under 50 [5][6].

To visualize this, a low-GI diet means eating:

  • Green Light (GI < 50): Non-starchy vegetables, beans, lentils, nuts, and certain whole grains.
  • Red Light (GI > 50): White bread, potatoes, sugary drinks, and processed sweets.

While daily carbohydrate intake is still capped at approximately 40 to 60 grams, this allowance is significantly more generous than the classic ketogenic diet, allowing caregivers to focus heavily on the quality (GI) of the permitted carbohydrates [6][7][5]. Meals are balanced with higher amounts of fats and adequate protein to support growth and development. By keeping blood sugar levels stable, the diet alters the brain’s metabolism in ways that can make it less prone to seizures [8][9].

How LGIT Differs from the Classic Ketogenic Diet

While both diets are used for seizure control, they differ significantly in their approach:

  • Carbohydrate Flexibility: The classic Ketogenic Diet (KD) requires a strict mathematical ratio of fats to carbohydrates and proteins (e.g., 4:1) [4][6]. The LGIT’s higher daily limit of 40-60 grams gives families much more flexibility in food choices and meal planning [2][10].
  • Palatability and Adherence: Because it allows for more varied carbohydrates, the LGIT is generally considered more palatable and easier to implement in daily life [11][12].
  • Side Effects: The LGIT is often reported to have fewer adverse physical effects (like severe constipation or extreme lethargy) and higher patient and caregiver acceptance compared to more restrictive diets [13][14][11]. However, any long-term dietary modification still carries potential nutritional and psychosocial risks that require monitoring [15].

How Effective is LGIT for Angelman Syndrome?

For patients with Angelman syndrome, LGIT is a recognized and viable therapeutic option with a favorable side-effect profile [1].

  • Seizure Reduction: Studies confirm that LGIT is effective in reducing seizure frequency in pediatric patients, specifically serving as a valuable alternative or supplement to traditional antiepileptic drugs for those with Angelman syndrome [1][16].
  • Expectations for Seizure Freedom: While LGIT is effective at reducing the number of seizures, complete seizure freedom is not always achieved, though some patients do reach this milestone [1][17][18].
  • Timeline and Adjustments: Finding the right balance and observing seizure reduction takes time. Families will need to work with their medical team to track progress over weeks or months to determine the diet’s specific effectiveness for their child.

Why You Need a Specialized Dietitian

Implementing any medical diet for epilepsy requires the guidance of a specialized medical team, including a registered dietitian.

  • Individualized Planning: Dietary therapies require careful risk-benefit assessments [11][9]. A dietitian will tailor the LGIT to the patient’s specific nutritional needs, growth requirements, and food preferences.
  • Transition Challenges: Children with Angelman syndrome often have sensory or behavioral challenges around food. A dietitian can help create transition strategies to slowly introduce new textures and low-GI foods.
  • Managing Complex Needs: Many individuals with Angelman syndrome have specific gastrointestinal issues (such as reflux or constipation) or specialized feeding needs, which a dietitian can help navigate while maintaining the principles of the LGIT.
  • Safety and Monitoring: A dietitian will regularly monitor blood work, track growth, and adjust the diet as needed to ensure safety and prevent nutritional deficiencies [15].

Common questions in this guide

What is the Low Glycemic Index Treatment (LGIT) diet?
The LGIT is a specialized dietary therapy used to help manage seizures. It restricts carbohydrates to foods with a glycemic index under 50, which prevents rapid spikes in blood sugar and alters the brain's metabolism to make it less prone to seizures.
How is the LGIT different from the classic ketogenic diet?
The LGIT allows for a more generous carbohydrate intake of 40 to 60 grams per day, focusing on the quality of carbs rather than strict mathematical ratios. This makes the LGIT much more flexible, palatable, and easier for families to maintain than the classic ketogenic diet.
Will the LGIT completely stop my child's seizures?
While the LGIT is highly effective at reducing seizure frequency for many patients with Angelman syndrome, complete seizure freedom is not always achieved. It is typically used to lower the number of seizures alongside other neurological treatments.
Do I need a dietitian to start the LGIT diet?
Yes, implementing the LGIT safely requires a specialized medical team, including a registered dietitian. They will tailor the diet to your child's growth needs, track blood work, and prevent nutritional deficiencies.
How long does it take to see if the LGIT is working for seizures?
Finding the right dietary balance takes time. Families should expect to work closely with their medical team and track progress over several weeks or months to determine if the diet is successfully reducing seizure frequency.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my child's current seizure frequency and medication plan, do you think they are a good candidate for the LGIT diet?
  2. 2.How would we monitor the effectiveness and safety of the LGIT diet over time, and what specific blood work would be required?
  3. 3.Can you refer us to a registered dietitian who specializes in neurological dietary therapies for children?
  4. 4.Do we need to adjust my child's current anti-epileptic medications when starting this diet?
  5. 5.If we start the LGIT, how many weeks or months should we trial the diet before determining if it is successfully reducing seizures?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Low glycemic index treatment for seizure control in Angelman syndrome: A case series from the Center for Dietary Therapy of Epilepsy at the Massachusetts General Hospital.

    Grocott OR, Herrington KS, Pfeifer HH, et al.

    Epilepsy & behavior : E&B 2017; (68()):45-50 doi:10.1016/j.yebeh.2016.12.018.

    PMID: 28109989
  2. 2

    Ketogenic Diets in the Management of Lennox-Gastaut Syndrome-Review of Literature.

    Skrobas U, Duda P, Bryliński Ł, et al.

    Nutrients 2022; (14(23)) doi:10.3390/nu14234977.

    PMID: 36501006
  3. 3

    The efficacy of low glycemic index diet on seizure frequency in pediatric patients with epilepsy: A systematic review and meta-analysis.

    Rohani P, Shervin Badv R, Sohouli MH, Guimarães NS

    Seizure 2024; (117()):150-158 doi:10.1016/j.seizure.2024.02.013.

    PMID: 38422595
  4. 4

    Dietary Therapies: Emerging Paradigms in Therapy of Drug Resistant Epilepsy in Children : Based on 6th Dr. I. C. Verma Excellence in Research Award Oration.

    Gulati S

    Indian journal of pediatrics 2018; (85(11)):1000-1005 doi:10.1007/s12098-018-2779-9.

    PMID: 30242606
  5. 5

    Ketogenic Diet in the Treatment of Epilepsy.

    Borowicz-Reutt K, Krawczyk M, Czernia J

    Nutrients 2024; (16(9)) doi:10.3390/nu16091258.

    PMID: 38732505
  6. 6

    Does the ketogenic ratio matter when using ketogenic diet therapy in pediatric epilepsy?

    Sharma S, Whitney R, Kossoff EH, RamachandranNair R

    Epilepsia 2023; (64(2)):284-291 doi:10.1111/epi.17476.

    PMID: 36471628
  7. 7

    Ketogenic diet: overview, types, and possible anti-seizure mechanisms.

    Barzegar M, Afghan M, Tarmahi V, et al.

    Nutritional neuroscience 2021; (24(4)):307-316 doi:10.1080/1028415X.2019.1627769.

    PMID: 31241011
  8. 8

    Evidenced-Based Nutrition for Gestational Diabetes Mellitus.

    Mahajan A, Donovan LE, Vallee R, Yamamoto JM

    Current diabetes reports 2019; (19(10)):94 doi:10.1007/s11892-019-1208-4.

    PMID: 31473839
  9. 9

    Clinical Efficacy and Safety of the Ketogenic Diet in Patients with Genetic Confirmation of Drug-Resistant Epilepsy.

    Na JH, Lee H, Lee YM

    Nutrients 2025; (17(6)) doi:10.3390/nu17060979.

    PMID: 40290041
  10. 10

    From clinical practice to mechanistic insights in ketogenic diets for epilepsy.

    Figueroa AG, Joshi CN, Patel MN

    The Lancet. Neurology 2026; (25(5)):519-532 doi:10.1016/S1474-4422(26)00008-6.

    PMID: 41831475
  11. 11

    Efficacy of Ketogenic Diet, Modified Atkins Diet, and Low Glycemic Index Therapy Diet Among Children With Drug-Resistant Epilepsy: A Randomized Clinical Trial.

    Sondhi V, Agarwala A, Pandey RM, et al.

    JAMA pediatrics 2020; (174(10)):944-951 doi:10.1001/jamapediatrics.2020.2282.

    PMID: 32761191
  12. 12

    Comparison of efficacy of low glycemic index treatment and modified Atkins diet among children with drug-resistant epilepsy: A randomized non-inferiority trial.

    Anand V, Gulati S, Agarwala A, et al.

    Epilepsia 2025; (66(5)):1550-1559 doi:10.1111/epi.18292.

    PMID: 39887979
  13. 13

    Modified Atkins Diet versus low glycemic index treatment in children with drug-resistant epilepsy: A systematic review and meta-analysis.

    Sharawat IK, Panda P, Dawman L, et al.

    Seizure 2025; (131()):471-479 doi:10.1016/j.seizure.2024.12.001.

    PMID: 39706756
  14. 14

    Efficacy and Safety of a Ketogenic Diet in Children and Adolescents with Refractory Epilepsy-A Review.

    Wells J, Swaminathan A, Paseka J, Hanson C

    Nutrients 2020; (12(6)) doi:10.3390/nu12061809.

    PMID: 32560503
  15. 15

    No improvement in quality of life in children with epilepsy treated with the low glycemic index diet.

    Boles S, Webster RJ, Parnel S, et al.

    Epilepsy & behavior : E&B 2020; (104(Pt A)):106664 doi:10.1016/j.yebeh.2019.106664.

    PMID: 31958641
  16. 16

    Efficacy of low glycemic index diet therapy (LGIT) in children aged 2-8 years with drug-resistant epilepsy: A randomized controlled trial.

    Lakshminarayanan K, Agarawal A, Panda PK, et al.

    Epilepsy research 2021; (171()):106574 doi:10.1016/j.eplepsyres.2021.106574.

    PMID: 33582533
  17. 17

    Efficacy and safety of antioxidants and dietary therapies for epilepsy: an umbrella meta-analysis.

    Feng Y, Cai S, Wang M, et al.

    Frontiers in nutrition 2025; (12()):1723370 doi:10.3389/fnut.2025.1723370.

    PMID: 41601892
  18. 18

    Low glycemic index treatment in patients with drug-resistant epilepsy.

    Kim SH, Kang HC, Lee EJ, et al.

    Brain & development 2017; (39(8)):687-692 doi:10.1016/j.braindev.2017.03.027.

    PMID: 28431772

This page provides educational information about the LGIT diet for Angelman syndrome. It does not replace professional medical advice, and any dietary therapy should be supervised by a specialized dietitian and neurologist.

Get notified when new evidence is published on Angelman syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.